IO Biotech, Inc. (IOBT)

IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $46.13 million. The enterprise value is $33.59 million.

Market Cap	46.13M
Enterprise Value	33.59M

Important Dates

The last earnings date was Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

IO Biotech has 71.95 million shares outstanding. The number of shares has increased by 0.31% in one year.

Current Share Class	71.95M
Shares Outstanding	71.95M
Shares Change (YoY)	+0.31%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	5.14%
Owned by Institutions (%)	13.75%
Float	43.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	49.06
P/TBV Ratio	50.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 19.89.

Current Ratio	2.01
Quick Ratio	1.73
Debt / Equity	19.89
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-80.82

Financial Efficiency

Return on equity (ROE) is -240.48% and return on invested capital (ROIC) is -122.91%.

Return on Equity (ROE)	-240.48%
Return on Assets (ROA)	-88.58%
Return on Invested Capital (ROIC)	-122.91%
Return on Capital Employed (ROCE)	-425.28%
Revenue Per Employee	n/a
Profits Per Employee	-$1.10M
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-955,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.67% in the last 52 weeks. The beta is 0.46, so IO Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-28.67%
50-Day Moving Average	0.79
200-Day Moving Average	1.22
Relative Strength Index (RSI)	39.27
Average Volume (20 Days)	880,295

Short Selling Information

The latest short interest is 2.43 million, so 3.37% of the outstanding shares have been sold short.

Short Interest	2.43M
Short Previous Month	2.76M
Short % of Shares Out	3.37%
Short % of Float	5.59%
Short Ratio (days to cover)	0.49

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-92.05M
Pretax Income	-89.30M
Net Income	-88.35M
EBITDA	-91.80M
EBIT	-92.05M
Earnings Per Share (EPS)	-$1.34

Balance Sheet

The company has $30.66 million in cash and $18.12 million in debt, giving a net cash position of $12.55 million or $0.17 per share.

Cash & Cash Equivalents	30.66M
Total Debt	18.12M
Net Cash	12.55M
Net Cash Per Share	$0.17
Equity (Book Value)	911,000
Book Value Per Share	0.01
Working Capital	18.52M

Cash Flow

In the last 12 months, operating cash flow was -$81.00 million and capital expenditures -$69,000, giving a free cash flow of -$81.07 million.

Operating Cash Flow	-81.00M
Capital Expenditures	-69,000
Free Cash Flow	-81.07M
FCF Per Share	-$1.13

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.31%
Shareholder Yield	-0.31%
Earnings Yield	-191.51%
FCF Yield	-175.72%

Analyst Forecast

The average price target for IO Biotech is $3.50, which is 445.85% higher than the current price. The consensus rating is "Buy".

Price Target	$3.50
Price Target Difference	445.85%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1